Seres Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | — | $-4.3M | $6.2M |
| FY2013 | — | $-11.1M | $1.7M |
| FY2014 | — | $-26.7M | $114.2M |
| FY2015 | — | $205.4M | $73.9M |
| FY2016 | — | $132.6M | $54.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | — | $-4.3M | $6.2M |
| FY2013 | — | $-11.1M | $1.7M |
| FY2014 | — | $-26.7M | $114.2M |
| FY2015 | — | $205.4M | $73.9M |
| FY2016 | — | $132.6M | $54.5M |